Featured Opioids Resources
This data note describes uninsured nonelderly adults with opioid use disorder, including their demographic characteristics, health status, and access to treatment.
Issue Brief See More
Related Opioids Resources
- The Role of Community Health Centers in Addressing the Opioid Epidemic
- The Opioid Epidemic and Medicaid’s Role in Facilitating Access to Treatment
- Federal Legislation to Address the Opioid Crisis: Medicaid Provisions in the SUPPORT Act
- How Connecting Justice-Involved Individuals to Medicaid Can Help Address the Opioid Epidemic
- A Look at How the Opioid Crisis Has Affected People with Employer Coverage
- HIV and the Opioid Epidemic: 5 Key Points
- Public Opinion on the Use and Abuse of Prescription Opioids
- Key Healthcare Proposals in Governors’ Proposed Budgets for SFY 2019 from a Preliminary Look at 32 States
- Medicaid and the Opioid Epidemic: Enrollment, Spending, and the Implications of Proposed Policy Changes
- Understanding Who Opioid Users Are Underscores Challenges
- The Washington Post/Kaiser Family Foundation Survey of Long-Term Prescription Painkiller Users and Their Household Members
- 1 in 5 Americans Say They Know Someone Who Has Died from Prescription Painkiller Overdose
- view as grid
- view as list
This issue brief provides an overview of Medicaid’s role in financing behavioral health services. It includes information on eligibility, benefits, service delivery, access to care, and spending. It also discusses the potential impact of Medicaid restructuring as proposed in the Better Care Reconciliation Act.
This infographic highlights Medicaid’s role in facilitating access to behavioral health treatment and the impact of potential reductions in federal Medicaid financing on behavioral health coverage and access to services.
The 21st Century Cures Act provided a billion dollars in new funding for opioid prevention and treatment. In this Wall Street Journal Think Tank column, Drew Altman looks at the challenges based on a new Kaiser-Washington Post survey of long term opioid users.
The Washington Post/Kaiser Survey: 1 in 3 Long-Term Prescription Painkiller Users Think They’re Addicted or Dependent
As the nation struggles with an ongoing epidemic of prescription painkiller abuse, misuse, and overdoses, a new Washington Post/Kaiser Family Foundation survey finds that one in three (34%) of those who recently used such drugs for at least two months report being addicted or dependent. Featured in Sunday’s The Washington…
The Washington Post/Kaiser Family Foundation Survey of Long-Term Prescription Painkiller Users and Their Household Members
This partnership poll from The Washington Post and the Kaiser Family Foundation examines the long-term use of prescription painkillers by exploring the views and experiences of adults 18 and over who they themselves, or a household member, have taken strong prescription painkillers for a period of two months or more at some time in the past two years, other than to treat pain from cancer or terminal illness. The survey takes a closer look at long-term users of prescription painkillers to better understand how they started taking these drugs, their interactions with medical providers, their concerns and experiences with addiction, and their views of efforts to stem the abuse of painkillers.
Where does President-elect Donald Trump stand on key health care issues? This snapshot outlines his positions and policy statements during the campaign on issues such as health insurance, the ACA, Medicaid, Medicare, the opioid epidemic, prescription drug costs, and women’s reproductive health.
Where do the 2016 Presidential candidates, Hillary Clinton and Donald Trump, stand on key health care issues? This snapshot outlines the candidates’ positions and policy statements on issues such as health insurance, the ACA, Medicaid, Medicare, the opioid epidemic, prescription drug costs, women’s reproductive health, and Zika.
Using Medicaid State Drug Utilization Data, this brief presents the 50 most costly drugs before rebates used by the Medicaid program over the January 2014 through June 2015 period. It then examines reasons why these drugs are so costly; explores case studies on opioids, hepatitis C drugs, and the drug Abilify; and considers policy implications.
Costly specialty drugs, such as those used to treat Hepatitis C and HIV, are among the most costly medications in state Medicaid programs, chiefly because of their high prices for a course of treatment, according to a new Kaiser Family Foundation analysis of Medicaid’s most costly outpatient drugs. Abilify, an…